Friday, October 04, 2019 1:38:50 PM
Item 9 Labs:10/3/19 Safety and Transparency Above All
As news of vaping sickness has overwhelmed the nation, we’ve heard from patients around the state concerned about the quality and safety of their medicinals.
We hear you.
At the time of this writing, hundreds of people have gotten sick with the mysterious illness, some fatally. The Centers for Disease Control (CDC) on Friday said they weren’t exactly sure what product or device is getting people sick, but that most cases of vaping illness involved nicotine and illicit THC-based vape products. What we do know is that many of the illness have been associated with black market or counterfeit products with names like Dank Vapes, Moon Rocks, Off White and TKO.
A report issued last week by the CDC noted that in 96 percent of cases, people who were sickened reported vaping THC from a cartridge that they had bought informally, like on the street or from a friend. The company Dank Vapes was associated with some 66 percent of the illnesses. “Dank Vapes appears to be the most prominent in a class of largely counterfeit brands, with common packaging that is easily available online and that is used by distributors to market THC-containing cartridges with no obvious centralized production or distribution,” the report read.
It’s important to note, however, that the CDC’s investigation is ongoing. It is possible that as more information flows in, the agency will uncover other chemicals, products, or brands linked to the cases. The most recent studies relied on what people told the CDC. It’s possible that they don’t remember correctly or aren’t sharing all the details of their vaping purchases or habits.
At Item 9 Labs, transparency is one of our most essential values. We want to ensure our patients feel totally clear about what goes into products that bear the Item 9 Labs name. What a better to share more with you about what goes into our proprietary offerings.
We pride ourselves on consistency, safety and potent, reliable doses that do what they are supposed to, so our patients can medicate with confidence—every time.
At Item 9 Labs, we control every aspect of our supply chain. Every step of production is thoughtfully refined to ensure that the medicine we produce is effective and safe for consumption, without fail. We give careful consideration to our choices in vape hardware to guarantee a safe consumption temperature, always free of heavy metals. Most importantly, every Item 9 Labs product is evaluated by a certified, independent, third-party testing facility.
These testing facilities offer an essential guarantee that products are what they say they are. This quality control check was put in place to regulate our market and keep dodgy players out of the game. Patients should always look for test results while purchasing cannabis or infused products.
Everything You Want, and Nothing You Don’t
At Item 9 Labs, we use only top-tier botanically and cannabis-derived terpenes. You will NEVER find lipid-based additives like Medium-Chain Triglycerides (MCT), Polyethylene Glycol (PEG), Propylene Glycol (PG), Vegetable Glycerin, and certainly no Vitamin E Acetate or any other kind of thickening agent in our vape cartridges or Apollo710 PODs.
We urge patients to buy vape cartridges solely from Arizona-state licensed dispensaries with required product labels containing the Batch ID, Dispensary Registration Certificate number, and an AZDHS warning statement.
Stay safe out there and stick with what you know!
Recent INLB News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 04:12:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:11:11 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:18:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/20/2023 09:10:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 09:16:07 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM